Sitryx Therapeutics in a £32M series A led by Oxford Science Enterprises

Biotech Health services Manufacturing Pharma

United Kingdom

France

United States

Investments

01 September 2023

Share:

Sitryx Therapeutics (company)

United Kingdom

Biotech Health services Manufacturing Pharma

Total investments received (USD): 39.68m

Round value (USD): 39.68m

Round investors: Oxford Science Enterprises Sofinnova Partners SV Health Investors Eli Lilly and Company Longwood Fund

Company: Sitryx Therapeutics

Industry: Biotech Health services Manufacturing Pharma

Related deals

Phagenesis raises $42m series D led by EQT Life Sciences and Sectoral Asset Management, w/ British Patient Capital, Northern Gritstone and Aphelion

Health services Pharma

United Kingdom

Sweden

United States

Canada

Investments 27 February 2024

Enterprise Therapeutics to raise £26M series B with Panakes Partners, Versant Ventures, Novartis Venture Fund, IP Group, Forbion Capital, Epidarex Capital

Health services Manufacturing Pharma

United Kingdom

United States

Netherlands

Switzerland

Italy

Investments 04 January 2024

Genomics plc to raise £35M from F-Prime Capital, Foresite Capital, MassMutual and Infinity Investment Partners

AI (big data) Biotech Health services Software Services

United Kingdom

United States

Investments 30 December 2023

Beckley Psytech in a $50 million deal, 40 of which capital raise, with atai Life Sciences.

Health services Manufacturing Pharma

United Kingdom

Germany

Investments 30 December 2023

Apollo Therapeutics raised $33.5m in an extended Series C funding led by Patient Square Capital, joined by M&G and Rock Springs Capital.

Biotech Manufacturing Pharma

United Kingdom

United States

Investments 03 December 2023